Ping An Healthcare and Technology Company Limited (HKG:1833) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected
Nov 17
Have your own idea? Try our Stock Screener
Hong Kong (HSI) Drug Retail Industry Analysis
UpdatedNov 21, 2024
DataAggregated Company Financials
Companies5
- 7D-0.3%
- 3M30.1%
- 1Y-23.2%
- YTDn/a
Last week, the Drug Retail industry hasn't moved much but JD Health International is up 5.7% in that time. As for the longer term, the industry has declined 24% in the last year. As for the next few years, earnings are expected to grow by 21% per annum.
Industry Valuation and Performance
Has the Hong Kong Drug Retail Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 21 Nov 2024 | HK$175.5b | HK$104.4b | HK$3.6b | 40.2x | 48.6x | 1.7x |
| Sat, 19 Oct 2024 | HK$171.1b | HK$104.8b | HK$3.3b | 49x | 51.4x | 1.6x |
| Mon, 16 Sep 2024 | HK$133.7b | HK$105.4b | HK$3.3b | 35.8x | 40x | 1.3x |
| Wed, 14 Aug 2024 | HK$133.7b | HK$103.0b | HK$2.4b | 39.9x | 55.4x | 1.3x |
| Fri, 12 Jul 2024 | HK$137.4b | HK$101.9b | HK$2.4b | 41.8x | 57.6x | 1.3x |
| Sun, 09 Jun 2024 | HK$161.7b | HK$102.2b | HK$2.4b | 50.1x | 67.5x | 1.6x |
| Tue, 07 May 2024 | HK$166.5b | HK$104.0b | HK$2.3b | 49.4x | 71.3x | 1.6x |
| Thu, 04 Apr 2024 | HK$151.0b | HK$103.9b | HK$2.3b | 45.2x | 64.8x | 1.5x |
| Sat, 02 Mar 2024 | HK$169.8b | HK$105.1b | -HK$1,456,456,790.59 | 56.5x | -116.6x | 1.6x |
| Mon, 29 Jan 2024 | HK$161.8b | HK$105.7b | -HK$1,464,110,334.00 | 52.2x | -110.5x | 1.5x |
| Wed, 27 Dec 2023 | HK$197.9b | HK$105.8b | -HK$1,465,895,761.00 | 61.3x | -135x | 1.9x |
| Fri, 24 Nov 2023 | HK$221.4b | HK$103.9b | -HK$1,763,865,808.00 | 88.9x | -125.5x | 2.1x |
| Sun, 22 Oct 2023 | HK$200.9b | HK$101.8b | -HK$1,735,746,037.00 | 83.9x | -115.8x | 2x |
| Tue, 19 Sep 2023 | HK$228.2b | HK$102.4b | -HK$1,676,388,383.00 | 90.7x | -136.1x | 2.2x |
| Thu, 17 Aug 2023 | HK$265.5b | HK$102.3b | -HK$2,681,973,197.00 | 87.2x | -99x | 2.6x |
| Sat, 15 Jul 2023 | HK$280.0b | HK$96.9b | -HK$4,202,451,199.00 | 120.2x | -66.6x | 2.9x |
| Mon, 12 Jun 2023 | HK$267.4b | HK$96.9b | -HK$4,286,907,700.00 | 248.9x | -62.4x | 2.8x |
| Wed, 10 May 2023 | HK$294.3b | HK$95.2b | -HK$4,876,757,306.00 | 442.3x | -60.4x | 3.1x |
| Fri, 07 Apr 2023 | HK$319.1b | HK$96.0b | -HK$4,913,647,545.00 | 481.7x | -64.9x | 3.3x |
Price to Earnings Ratio
-201.2x
Current Industry PE
- Investors are pessimistic on the Hong Kong Drug Retail industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 48.1x which is lower than its 3-year average PE of 116x.
- The 3-year average PS ratio of 2.0x is higher than the industry's current PS ratio of 1.7x.
Past Earnings Growth
- Total earnings for the Drug Retail industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 4.7% per year.
- This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.
Industry Comparison
How does Hong Kong Drug Retail compare with similar industries?
| HK Market | 0.42% | |
| Consumer Staples | -0.31% | |
| Food and Staples Retail | -0.24% | |
| Drug Retail | -0.27% | |
| Big Box Super Stores | 6.47% | |
| Food Distributors | -0.53% | |
| Food Retail | -4.77% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 6618 JD Health International | HK$28.60 | 7.9% +HK$6.7b | -29.2% | PE32.4x | |
| 314 Sipai Health Technology | HK$5.60 | 7.1% +HK$282.5m | -23.3% | PS0.9x | |
| 9886 Dingdang Health Technology Group | HK$0.58 | 1.8% +HK$13.3m | -74.6% | PS0.1x |
